Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
Youku Tudou Inc. (NYSE: YOKU) shares closed up 11.15 percent this past Friday with nearly 13.8 million shares traded. The stock was one of the biggest volume leaders on the NYSE that day. The Company released a strong set of third-quarter results and favorable guidance for its fourth quarter. The company saw a jump in average daily video views to more than 300 million.
Get more information on Youku Tudou Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/YOKU
Pan Global Corp. (OTC: PGLO) shares closed up 29.55% on Friday with about 3.7 million shares traded. The Company announced that it has commenced planning for further restructuring and improvements of its share capital to provide additional capitalization benefits to its shareholders. The stock traded in between 0.4501 - 0.57 a share.
Get more information on Pan Global Corp. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/PGLO
Endeavor IP, Inc. (OTCBB: ENIP) shares closed down 26.42 percent on Friday on about 1.5 million shares traded. The stock traded in between 0.56 and 0.90 with 0.90 becoming a new 52-week high for the stock. The company was negatively featured in a SeekingAlpha article last week but had no significant news since earlier this month.
Get more information on Endeavor IP, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/ENIP
Cadence Pharmaceuticals Inc. (NASDAQ: CADX) shares closed up 34.01 percent on Friday and traded in between 7.00 - 9.39, with 9.39 becoming a new 52-week high for the stock. Volume traded was about 8.5 million shares. The stock had one of the biggest percentage increases on the NASDAQ which came after the Company received a favorable ruling from the U.S. District Court for the District of Delaware in its patent suit against Exela Pharma Sciences.
Get more information on Cadence Pharmaceuticals Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/CADX
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.